Skip to main navigation Skip to search Skip to main content

Ganglioside GM1 mimicry in Campylobacter strains from sporadic infections in the United States

  • Irving Nachamkin
  • , Huong Ung
  • , Anthony P. Moran
  • , Dale Yoo
  • , MARTINA PRENDERGAST
  • , Mabel A. Nicholson
  • , Kazim Sheikh
  • , Tony Ho
  • , Arthur K. Asbury
  • , Guy M. McKhann
  • , John W. Griffin

Research output: Contribution to a Journal (Peer & Non Peer)Articlepeer-review

Abstract

To determine whether GM1-like epitopes in Campylobacter species are specific to O serotypes associated with Guillain-Barre syndrome (GBS) or whether they are frequent among random Campylobacter isolates causing enteritis, 275 random enteritis-associated isolates of Campylobacter jejuni were analyzed. The isolates were collected in the United States using a cholera toxin-binding assay. Overall, 26.2% of the isolates were positive for the GM1-like epitope. Of the 36 different O serotypes in the sample, 21 (58.3%) contained no strains positive for GM1, whereas in 6 serotypes (16.7%), 50% of isolates were positive for GM1. GBS-associated serotypes were more likely to contain strains positive for GM1 than were non-GBS-associated serotypes (37.8% vs. 15.1%, P = .0116). The results suggest that humans are frequently exposed to strains exhibiting GM1-like mimicry and, while certain serotypes may be more likely to possess GM1-like epitopes, the presence of GM1-like epitopes on Campylobacter strains does not itself trigger GBS.
Original languageEnglish (Ireland)
Number of pages7
JournalJournal Of Infectious Diseases
Volume179
DOIs
Publication statusPublished - 1 May 1999

Fingerprint

Dive into the research topics of 'Ganglioside GM1 mimicry in Campylobacter strains from sporadic infections in the United States'. Together they form a unique fingerprint.

Cite this